Adverse vacuolation in multiple tissues in cynomolgus monkeys following repeat-dose administration of a PEGylated protein
Anthony M. Fletcher(The Bristol-Myers Squibb Children's Hospital), William E. Achanzar(Bristol-Myers Squibb (Germany)), Julie Douville(Charles River Laboratories (Netherlands)), Peter W. A. Mansell(The University of Texas MD Anderson Cancer Center), Thomas A. Brodie(Bristol-Myers Squibb (United States)), Michael J. Graziano(The Bristol-Myers Squibb Children's Hospital), Pierre Tellier(TransCanada (Canada)), Raja S. Mangipudy(Bristol-Myers Squibb (United States))
Cited by 23
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Effects of cadmium on DNA-(Cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation
|Experimental Cell Research|2003|450
Pharmacokinetics of recombinant interleukin 2 in humans.
|Unknown|1990|216
A nematode gene required for sperm vesicle fusion
|Journal of Cell Science|1997|184